Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat ...
This article and associated images are based on a poster originally authored by Daniela Flehberger, Sofia Buianova, Emma Langguth, Johanna Irnstorfer, Stefanie Fellinger, Henrik Schmidt, Adam Krejci, ...
The rapid evolution of screening platforms is transforming how laboratory professionals identify and validate therapeutic candidates. Implementing these advanced systems accelerates pipelines while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results